Table 2.
Factors influencing seizure worsening.
| Features | WPwE | NWPwE | Predictor (OR) |
|---|---|---|---|
| Age | 37.6 ± 12 | 41.19 ± 12 | n.s. |
| Sex | 54 F; 13 M | 290 F; 54 M | n.s. |
| GAD-7 | 10.8 ± 5.4 | 7.5 ± 5.12 | n.s. |
| BDI-II | 17.69 ± 9.99 | 10.99 ± 9.64 | n.s. |
| PSQI | 9.40 ± 4.07 | 6.40 ± 3.52 | 1.20 |
| Work situation change | 41 Yes; 26 No | 260 Yes; 84 No | n.s. |
| History of depression | 9 Yes; 58 No | 26 Yes; 363 No | n.s. |
| Number ASM | 2.5 ± 1 | 1.9 ± 1 | 1.58 |
| N. Seizures/month pre-COVID-19 | 5.18 ± 4 | 2.26 ± 4 | n.s. |
ASM, anti-seizure medication; BDI-II, Beck Depression Inventory-II; PSQI, Pittsburgh Sleep Quality Index; n.s., not significant. Bold values are for statistically significant variables surviving after stepwise selection during the logistic regression.